PMID: 6107275Jan 1, 1980Paper

Genetic resistance of CBA and A mice to transplanted lymphoid and hemopoietic cells of CBA.M523 mutants and their F1 hybrids

Immunogenetics
L N FontalinZ K Blandova

Abstract

(CBA X M523)F1, (A X M523)F1 and M523 lymphocytes grafted into lethally irradiated CBA or A mice temporarily lose their capacity to respond to test antigens (SRBC, Vi-antigen, S. typhi). Immunoresponsiveness of F1 cells is affected to a lesser degree in lethally irradiated M523 mice. Depression of response is absent in the CBA leads to F1 combination, in the syngeneic combination and in CBA mice whch have received transplanted cells from F1 hybrids which do not share the M523 mutation. The number of hemopoietic (CBA X M523)F1 colonies was also reduced in CBA mice. Resistance of CBA mice to lymphoid (CBA X M523)F1 cells develops 18 days after birth. It can be reduced by additional recipient preirradiation or preinoculation with (CBA X M523)F1 spleen cells. The abrogated resistance can be partially restored by CBA spleen cells. The activity of (CBA X M523)F1 lymphocytes passaged through CBA spleen is restored in syngeneic F1 secondary recipients but inhibited again in the CBA secondary recipients. These results are consistent with the suggestion that resistance of lethally irradiated CBA mice to hemopoietic and lymphoid (CBA X M523)F1 cells is mediated by immunologically competent, radioresistant recipient cells rapidly reacting ...Continue Reading

References

Mar 1, 1979·Biulleten' eksperimental'noĭ biologii i meditsiny·L N FontalinZ K Blandova
Aug 15, 1975·International Journal of Cancer. Journal International Du Cancer·R B HerbermanD H Lavrin
Feb 1, 1977·European Journal of Immunology·A LengerováI Hilgert
Mar 1, 1975·Cell and Tissue Kinetics·W A BuurmanO Vos
Jul 1, 1971·The Journal of Experimental Medicine·G Cudkowicz, M Bennett
Feb 26, 1965·Science·G CUDKOWICZ, J H STIMPFLING
Mar 1, 1965·Transplantation·D K BORAKER, W H HILDEMANN
Apr 26, 1963·Science·N K Jerne, A A Nordin

❮ Previous
Next ❯

Citations

Mar 1, 1983·Biulleten' eksperimental'noĭ biologii i meditsiny·T K Kondrat'evaZ K Blandova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.